{"transactions":[{"id":2022495,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-10T16:13:14.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest at the rate of 1/48th of the original number of shares on each monthly anniversary of January 1, 2023, subject to the reporting person's continuous service to the issuer on each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":4.01,"expiration_date":"2033-02-07","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-008336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919123008336/doc4.xml","form_type":"4"}},{"id":2411567,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T17:26:37.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest at the rate of 1/48th of the original number of shares on each monthly anniversary of January 1, 2022, subject to the reporting person's continuous service to the issuer on each such vesting date."}],"balance_after":175000,"derivative":{"exercise_price":0.55,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-22-007266","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919122007266/doc4.xml","form_type":"4"}},{"id":2890119,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-29T16:13:23.000Z","date":"2021-01-27","kind":"grant","acquired":true,"shares":415000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest at the rate of 1/48th of the original number of shares on each monthly anniversary of January 1, 2021, subject to the  reporting person's continuous service to the issuer on each such vesting date."}],"balance_after":415000,"derivative":{"exercise_price":2.68,"expiration_date":"2031-01-26","underlying":"Common Stock","underlying_shares":415000},"source":{"system":"sec-edgar","filing":"0001209191-21-006081","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919121006081/doc4.xml","form_type":"4"}},{"id":2946350,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-14T20:58:00.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":23954,"price":2.94,"value":70424.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.93 to $2.97. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":339782,"source":{"system":"sec-edgar","filing":"0001209191-20-063366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919120063366/doc4.xml","form_type":"4"}},{"id":2946349,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-14T20:58:00.000Z","date":"2020-12-11","kind":"sale","acquired":false,"shares":48046,"price":2.9,"value":139333.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.90 to $2.93. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and\nExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in\nthis footnote."}],"balance_after":363736,"source":{"system":"sec-edgar","filing":"0001209191-20-063366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919120063366/doc4.xml","form_type":"4"}},{"id":2948463,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-11T20:43:06.000Z","date":"2020-12-09","kind":"exercise","acquired":false,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options were scheduled to expire on February 8, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were fully vested as of February 9, 2015."}],"balance_after":0,"derivative":{"exercise_price":0.4,"expiration_date":"2021-02-08","underlying":"Common Stock","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001209191-20-063099","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919120063099/doc4.xml","form_type":"4"}},{"id":2948462,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-11T20:43:06.000Z","date":"2020-12-09","kind":"exercise","acquired":true,"shares":72000,"price":0.4,"value":28800.0,"ownership":{"direct":true},"balance_after":411782,"source":{"system":"sec-edgar","filing":"0001209191-20-063099","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919120063099/doc4.xml","form_type":"4"}},{"id":3040948,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-09-02T08:30:18.000Z","date":"2020-09-01","kind":"other","acquired":true,"shares":20238,"price":1.05,"value":21249.9,"ownership":{"direct":true},"balance_after":339782,"source":{"system":"sec-edgar","filing":"0001209191-20-049016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919120049016/doc4.xml","form_type":"4"}},{"id":3231760,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-03T20:25:45.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":325000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-half of the stock options will vest in 48 equal monthly installments over the four-year period beginning on January 1, 2020, subject to the reporting person's continued service to the issuer through each such vesting date.  The other one-half of the stock options will vest in 48 equal monthly installments over the four-year period beginning on the date, if any, on which the U.S. Food and Drug Administration approves the Issuer's new drug application for Gimoti, subject to the reporting person's continued service to the issuer through each such vesting date."}],"balance_after":325000,"derivative":{"exercise_price":1.23,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":325000},"source":{"system":"sec-edgar","filing":"0001209191-20-015796","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919120015796/doc4.xml","form_type":"4"}},{"id":3484012,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-19T16:37:26.000Z","date":"2019-06-17","kind":"grant","acquired":false,"shares":168750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on June 17, 2019, subject to the reporting person's continued service to the Issuer through each such vesting date."}],"balance_after":168750,"derivative":{"exercise_price":0.62,"expiration_date":"2029-02-05","underlying":"Common Stock","underlying_shares":168750},"source":{"system":"sec-edgar","filing":"0001209191-19-038036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919119038036/doc4.xml","form_type":"4"}},{"id":3484011,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-19T16:37:26.000Z","date":"2019-06-17","kind":"grant","acquired":false,"shares":168750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on June 17, 2019, subject to the reporting person's continued service to the Issuer through each such vesting date."}],"balance_after":168750,"derivative":{"exercise_price":0.62,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":168750},"source":{"system":"sec-edgar","filing":"0001209191-19-038036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919119038036/doc4.xml","form_type":"4"}},{"id":3484010,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-19T16:37:26.000Z","date":"2019-06-17","kind":"grant","acquired":false,"shares":168750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on June 17, 2019, subject to the reporting person's continued service to the Issuer through each such vesting date."}],"balance_after":168750,"derivative":{"exercise_price":0.62,"expiration_date":"2017-01-24","underlying":"Common Stock","underlying_shares":168750},"source":{"system":"sec-edgar","filing":"0001209191-19-038036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919119038036/doc4.xml","form_type":"4"}},{"id":3484009,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-19T16:37:26.000Z","date":"2019-06-17","kind":"grant","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on June 17, 2019, subject to the reporting person's continued service to the Issuer through each such vesting date."}],"balance_after":45000,"derivative":{"exercise_price":0.62,"expiration_date":"2026-02-04","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-19-038036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919119038036/doc4.xml","form_type":"4"}},{"id":3484008,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-19T16:37:26.000Z","date":"2019-06-17","kind":"grant","acquired":false,"shares":53015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on June 17, 2019, subject to the reporting person's continued service to the Issuer through each such vesting date."}],"balance_after":53015,"derivative":{"exercise_price":0.62,"expiration_date":"2026-02-04","underlying":"Common Stock","underlying_shares":53015},"source":{"system":"sec-edgar","filing":"0001209191-19-038036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919119038036/doc4.xml","form_type":"4"}},{"id":3484007,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-19T16:37:26.000Z","date":"2019-06-17","kind":"grant","acquired":false,"shares":63750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on June 17, 2019, subject to the reporting person's continued service to the Issuer through each such vesting date."}],"balance_after":63750,"derivative":{"exercise_price":0.62,"expiration_date":"2026-01-27","underlying":"Common Stock","underlying_shares":63750},"source":{"system":"sec-edgar","filing":"0001209191-19-038036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919119038036/doc4.xml","form_type":"4"}},{"id":3484006,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-19T16:37:26.000Z","date":"2019-06-17","kind":"disposition_to_issuer","acquired":true,"shares":225000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"On June 17, 2019, the Issuer canceled an option granted on February 6, 2019. In exchange for the canceled option, the reporting person received 168,750 options to purchase common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on January 1, 2019, subject to the reporting person's continued service to the Issuer through each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":2.94,"expiration_date":"2029-02-05","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-19-038036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919119038036/doc4.xml","form_type":"4"}},{"id":3484005,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-19T16:37:26.000Z","date":"2019-06-17","kind":"disposition_to_issuer","acquired":true,"shares":225000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"On June 17, 2019, the Issuer canceled an option granted on February 7, 2018. In exchange for the canceled option, the reporting person received 168,750 options to purchase common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option grant date was February 7, 2018, subject to approval of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"Plan\") by the Issuer's stockholders which occurred at the Issuer's annual stockholder meeting on April 26, 2018. The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on January 1, 2018, subject to the reporting person's continued service to the Issuer through each such vesting date. Notwithstanding the foregoing vesting schedule, in no event may the option be exercised prior to the earlier of (i) the date on which the Issuer receives marketing approval from the U.S. Food and Drug Administration of Gimoti, (ii) the second anniversary of the date of grant, or (iii) the date of a \"change in control\" under Section 2.9 of the Plan."}],"balance_after":0,"derivative":{"exercise_price":2.43,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-19-038036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919119038036/doc4.xml","form_type":"4"}},{"id":3484004,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-19T16:37:26.000Z","date":"2019-06-17","kind":"disposition_to_issuer","acquired":true,"shares":225000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On June 17, 2019, the Issuer canceled an option granted on January 25, 2017. In exchange for the canceled option, the reporting person received 168,750 options to purchase common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on January 1, 2017, subject to the reporting person's continued service to the Issuer through each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":2.36,"expiration_date":"2027-01-24","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-19-038036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919119038036/doc4.xml","form_type":"4"}},{"id":3484003,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-19T16:37:26.000Z","date":"2019-06-17","kind":"disposition_to_issuer","acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On June 17, 2019, the Issuer canceled an option granted on February 5, 2016. In exchange for the canceled option, the reporting person received 45,000 options to purchase common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The total number of shares of common stock subject to the option vests in 36 equal monthly installments over the three-year period beginning on January 1, 2016, subject to the reporting person's continued service to the Issuer through each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.04,"expiration_date":"2026-02-04","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-19-038036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919119038036/doc4.xml","form_type":"4"}},{"id":3484002,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-19T16:37:26.000Z","date":"2019-06-17","kind":"disposition_to_issuer","acquired":true,"shares":70687,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On June 17, 2019, the Issuer canceled an option granted on February 5, 2016. In exchange for the canceled option, the reporting person received 53,015 options to purchase common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The total number of shares of common stock subject to the option vests in 36 equal monthly installments over the three-year period beginning on January 1, 2016, subject to the reporting person's continued service to the Issuer through each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.04,"expiration_date":"2026-02-04","underlying":"Common Stock","underlying_shares":70687},"source":{"system":"sec-edgar","filing":"0001209191-19-038036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919119038036/doc4.xml","form_type":"4"}},{"id":3484001,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-19T16:37:26.000Z","date":"2019-06-17","kind":"disposition_to_issuer","acquired":true,"shares":85000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 17, 2019, the Issuer canceled an option granted on January 28, 2016. In exchange for the canceled option, the reporting person received 63,750 options to purchase common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on January 1, 2016, subject to the reporting person's continued service to the Issuer through each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.07,"expiration_date":"2026-01-27","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001209191-19-038036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919119038036/doc4.xml","form_type":"4"}},{"id":3667931,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-08T16:03:08.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on January 1, 2019, subject to the reporting person's continued service to the Issuer through each such vesting date."}],"balance_after":225000,"derivative":{"exercise_price":2.94,"expiration_date":"2029-02-05","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-19-008467","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919119008467/doc4.xml","form_type":"4"}},{"id":3825235,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-09-05T10:17:35.000Z","date":"2018-08-31","kind":"other","acquired":true,"shares":6901,"price":1.63,"value":11248.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased under the Issuer's Employee Stock Purchase Plan in transactions exempt under Rule 16b-3(c)."}],"balance_after":319544,"source":{"system":"sec-edgar","filing":"0001209191-18-049421","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919118049421/doc4.xml","form_type":"4"}},{"id":3954882,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-27T16:16:50.000Z","date":"2018-04-26","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant date was February 7, 2018, subject to approval of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"Plan\") by the Issuer's stockholders which occurred at the Issuer's annual stockholder meeting on April 26, 2018.  The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on January 1, 2018, subject to the reporting person's continued service to the Issuer through each such vesting date. Notwithstanding the foregoing vesting schedule, in no event may the option be exercised prior to the earlier of (i) the date on which the Issuer receives marketing approval from the U.S. Food and Drug Administration of Gimoti, (ii) the second anniversary of the date of grant, or (iii) the date of a \"change in control\" under Section 2.9 of the Plan."}],"balance_after":225000,"derivative":{"exercise_price":2.43,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-18-026555","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919118026555/doc4.xml","form_type":"4"}},{"id":4217744,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-09-05T16:38:44.000Z","date":"2017-08-31","kind":"other","acquired":true,"shares":8240,"price":2.15,"value":17716.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's Employee Stock Purchase Plan in transactions exempt under Rule 16b-3(c)."}],"balance_after":312643,"source":{"system":"sec-edgar","filing":"0001209191-17-051339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919117051339/doc4.xml","form_type":"4"}},{"id":4409073,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-03-02T06:41:55.000Z","date":"2017-02-28","kind":"other","acquired":true,"shares":12000,"price":1.6,"value":19200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's Employee Stock Purchase Plan in transactions exempt under Rule 16b-3(c)."}],"balance_after":304403,"source":{"system":"sec-edgar","filing":"0001209191-17-016247","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919117016247/doc4.xml","form_type":"4"}},{"id":4461210,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-08T20:50:08.000Z","date":"2017-02-08","kind":"exercise","acquired":false,"shares":1200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the \"Reverse Split\"), and the number of securities and/or the exercise price reported reflect the Reverse Split."},{"field":"shares","element":"transactionShares","label":"F1","text":"On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the \"Reverse Split\"), and the number of securities and/or the exercise price reported reflect the Reverse Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option initially vested and became exercisable in twelve equal monthly installments beginning on June 30, 2016 and ending on May 31, 2017. However, upon approval of the issuer's board of directors, vesting was accelerated and the option became fully vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the \"Reverse Split\"), and the number of securities and/or the exercise price reported reflect the Reverse Split."}],"balance_after":0,"derivative":{"exercise_price":7.65,"expiration_date":"2026-06-15","underlying":"Common Stock","underlying_shares":1200},"source":{"system":"sec-edgar","filing":"0000899243-17-003211","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1578768/000089924317003211/doc4.xml","form_type":"4"}},{"id":4461209,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-08T20:50:08.000Z","date":"2017-02-08","kind":"exercise","acquired":true,"shares":1200,"price":7.65,"value":9180.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the \"Reverse Split\"), and the number of securities and/or the exercise price reported reflect the Reverse Split."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the \"Reverse Split\"), and the number of securities and/or the exercise price reported reflect the Reverse Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the \"Reverse Split\"), and the number of securities and/or the exercise price reported reflect the Reverse Split."}],"balance_after":1899,"source":{"system":"sec-edgar","filing":"0000899243-17-003211","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578768/000089924317003211/doc4.xml","form_type":"4"}},{"id":4479093,"issuer":{"id":71094,"kind":"organization","name":"Evoke Pharma Inc","symbol":"EVOK"},"owners":[{"id":117042,"kind":"person","name":"Gonyer David A","position":1,"cik":"0001578768","reported_name":"Gonyer David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-27T17:58:33.000Z","date":"2017-01-25","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on January 1, 2017, subject to the reporting person's continued service to the Issuer through each such vesting date."}],"balance_after":225000,"derivative":{"exercise_price":2.36,"expiration_date":"2027-01-24","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-17-005985","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403708/000120919117005985/doc4.xml","form_type":"4"}}]}